一般外科

Medicine & Life Sciences

1. Advanced Glycation End Products 8%
2. antrocin 6%
3. Antrodia 10%
4. Apoptosis 13%
5. Appendectomy 9%
6. Appendicitis 6%
7. Autophagy 10%
8. Bariatric Surgery 11%
9. Body Mass Index 6%
10. Breast 12%
11. Breast Neoplasms 47%
12. Carcinogenesis 12%
13. Carcinoma 7%
14. Catenins 6%
15. Cell Line 6%
16. Cell Movement 20%
17. Cohort Studies 8%
18. Colon 8%
19. Colonic Neoplasms 23%
20. Colorectal Neoplasms 30%
21. Confidence Intervals 30%
22. Curcumin 13%
23. Databases 10%
24. destruxin B 6%
25. Down-Regulation 13%
26. Drug Therapy 9%
27. Epithelial-Mesenchymal Transition 11%
28. ErbB Receptors 6%
29. Fluorouracil 8%
30. Gastrectomy 12%
31. Gastric Bypass 11%
32. gemcitabine 7%
33. Gene Expression 7%
34. Genes 7%
35. glucose-regulated proteins 31%
36. Growth 8%
37. Hemorrhage 6%
38. Hemorrhoidectomy 6%
39. Hepatocellular Carcinoma 35%
40. Herniorrhaphy 6%
41. Heterografts 6%
42. Hormones 6%
43. Hydrogen Peroxide 6%
44. In Vitro Techniques 6%
45. Incidence 14%
46. Intussusception 7%
47. Laparoscopy 14%
48. Learning Curve 8%
49. Length of Stay 9%
50. Libraries 11%
51. Liver 14%
52. Lung 8%
53. Lung Neoplasms 10%
54. Macrophages 8%
55. Meta-Analysis 100%
56. MicroRNAs 14%
57. Morbid Obesity 8%
58. Mortality 7%
59. Neoplasm Metastasis 29%
60. Neoplasms 39%
61. Neoplastic Stem Cells 12%
62. Nicotine 17%
63. Nicotinic Receptors 23%
64. Odds Ratio 14%
65. p38 Mitogen-Activated Protein Kinases 6%
66. Paclitaxel 6%
67. Pain 11%
68. Phloretin 6%
69. Population 11%
70. Prostatic Neoplasms 6%
71. Proteins 7%
72. pterostilbene 17%
73. PubMed 13%
74. Quality of Life 9%
75. Randomized Controlled Trials 64%
76. Rectal Neoplasms 25%
77. Recurrence 8%
78. Resveratrol 6%
79. Robotics 16%
80. Safety 11%
81. SERPIN-B5 6%
82. Serum 9%
83. Shared Decision Making 6%
84. Small Interfering RNA 7%
85. Smoking 8%
86. Sorafenib 6%
87. Stomach 10%
88. Stomach Neoplasms 12%
89. Survival 12%
90. Survivin 7%
91. Systematic Reviews 49%
92. Taiwan 26%
93. Therapeutics 20%
94. Thrombomodulin 9%
95. Thyroid Neoplasms 6%
96. Transanal Endoscopic Surgery 7%
97. Triple Negative Breast Neoplasms 11%
98. Up-Regulation 8%
99. Weight Loss 8%
100. Wounds and Injuries 6%